- Report
- March 2023
- 80 Pages
China
From €1348EUR$1,500USD£1,154GBP
From €1348EUR$1,500USD£1,154GBP
- Report
- March 2023
- 80 Pages
South Korea
From €1348EUR$1,500USD£1,154GBP
- Report
- February 2026
- 253 Pages
India
From €4357EUR$4,850USD£3,732GBP
- Report
- February 2026
- 307 Pages
Germany
From €4357EUR$4,850USD£3,732GBP
- Report
- February 2026
- 150 Pages
Canada
From €4357EUR$4,850USD£3,732GBP
- Report
- November 2025
- 108 Pages
Philippines
From €2675EUR$3,190USD£2,371GBP
- Report
- October 2025
- 120 Pages
France
From €2675EUR$3,190USD£2,371GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,186USD£882GBP
- Report
- October 2025
- 81 Pages
Uruguay
From €2675EUR$3,190USD£2,371GBP
- Report
- October 2025
- 103 Pages
Netherlands
From €2675EUR$3,190USD£2,371GBP
- Report
- September 2025
- 50 Pages
Lebanon
From €2150EUR$2,564USD£1,906GBP
- Report
- September 2025
- 101 Pages
Argentina
From €2675EUR$3,190USD£2,371GBP
- Report
- July 2025
- 210 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- June 2025
- 150 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- April 2025
- 132 Pages
Global
From €4357EUR$4,850USD£3,732GBP
- Report
- March 2024
- 132 Pages
Global
From €4177EUR$4,650USD£3,578GBP
- Database
- July 2023
Global
From €323EUR$360USD£277GBP
- Report
- April 2023
- 65 Pages
India
- Report
- November 2022
- 76 Pages
Global
From €1797EUR$2,000USD£1,539GBP

The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more